Compare DexCom, Inc. (DXCM) vs Pinterest Inc (PINS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Pinterest Inc — how do they compare? DexCom, Inc. trades at $77.78 (market cap $28.06B), while Pinterest Inc trades at $23.51 (market cap $13.26B). The key difference: DexCom, Inc. is far larger — about 2.1× Pinterest Inc's market cap, and DexCom, Inc. is trading nearer its 52-week high, Pinterest Inc nearer its low. Which is the better fit depends on your goals.
| DXCM | PINS | |
|---|---|---|
Market Cap | $28.06B | $13.26B |
Sector | Health | Media |
52-Week High | $89.53 | $39.17 |
52-Week Low | $54.84 | $15.42 |
Enterprise Value | $27.03B | $13.17B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $74.12, down 2.92% on the day, with a bullish technical signal from moving averages. The company demonstrates strong fundamentals with consistent revenue growth, expanding profit margins, and a track record of beating earnings estimates. Recent regulatory approvals for its G7 15-day CGM in Canada and pediatric clearance for its Stelo OTC system in the U.S. highlight ongoing product expansion.
The investment thesis centers on DexCom's leadership in the growing CGM market, supported by strong financial execution and analyst optimism. Key risks include competition from Abbott, the commercial unproven nature of expansion into non-insulin Type 2 diabetes patients, and potential disruption from GLP-1 drug adoption. The consensus price target of $84.33 suggests ~14% upside from current levels.
Pinterest (PINS) trades at $22.605, showing minimal daily movement. The stock exhibits a bullish technical setup with strong analyst support (54% buy ratings) and a consensus price target of $27.72, suggesting 23% upside. Fundamentally, the company demonstrates robust revenue growth to $4.22B in 2025 and improving profitability with a 7.64% net margin, though valuation metrics remain elevated with a P/E of 49.33. Recent developments include AI shopping initiatives and strong user growth to 631M MAUs in Q1 2026.
The outlook for PINS is cautiously optimistic with clear catalysts from AI-driven monetization and e-commerce integration, but risks include high valuation multiples and competitive pressures in social commerce. Earnings momentum is mixed with a recent beat in Q1 2026 but a miss in Q3 2025. The stock's investment case hinges on sustained user growth translating to higher ARPU and margin expansion.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Pinterest Inc
Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.
Read more on PINS →
